Press Releases

Read our latest announcements

Filter by year:

2014-05-30
Modus Therapeutics presents results from exploratory Phase I/II clinical trial in uncomplicated malaria

Modus Therapeutics AB announced the results from an exploratory Phase I/II clinical trial in malaria with its candidate drug sevuparin.

View Press Release
2014-01-22
Christina Herder appointed CEO of Modus Therapeutics

Modus Therapeutics AB announces that Christina Herder has been appointed as its new Chief Executive Officer.

View Press Release